BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hwang CJ, Park MH, Hwang JY, Kim JH, Yun NY, Oh SY, Song JK, Seo HO, Kim YB, Hwang DY, Oh KW, Han SB, Hong JT. CCR5 deficiency accelerates lipopolysaccharide-induced astrogliosis, amyloid-beta deposit and impaired memory function. Oncotarget 2016;7:11984-99. [PMID: 26910914 DOI: 10.18632/oncotarget.7453] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Bauss J, Morris M, Shankar R, Olivero R, Buck LN, Stenger CL, Hinds D, Mills J, Eby A, Zagorski JW, Smith C, Cline S, Hartog NL, Chen B, Huss J, Carcillo JA, Rajasekaran S, Bupp CP, Prokop JW. CCR5 and Biological Complexity: The Need for Data Integration and Educational Materials to Address Genetic/Biological Reductionism at the Interface of Ethical, Legal, and Social Implications. Front Immunol 2021;12:790041. [PMID: 34925370 DOI: 10.3389/fimmu.2021.790041] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Xu S, Xu J, Hao T, Yan Y, Zhang S, Li A, Shi C, Liu Q, Zhao J. Paeonol alleviates lipopolysaccharide‑induced hepatocytes injury through alteration of mitochondrial function and NF‑κB translocation. Mol Med Rep 2021;24:779. [PMID: 34498704 DOI: 10.3892/mmr.2021.12419] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Wang H, Shen Y, Chuang H, Chiu C, Ye Y, Zhao L. Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices. Curr Alzheimer Res 2019;16:659-74. [PMID: 31580243 DOI: 10.2174/1567205016666190503151648] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
4 Rautenbach A, Williams AA. Metabolomics as an Approach to Characterise the Contrasting Roles of CCR5 in the Presence and Absence of Disease. Int J Mol Sci 2020;21:E1472. [PMID: 32098198 DOI: 10.3390/ijms21041472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ellwanger JH, Kaminski VL, Chies JA. What we say and what we mean when we say redundancy and robustness of the chemokine system - how CCR5 challenges these concepts. Immunol Cell Biol 2020;98:22-7. [PMID: 31613403 DOI: 10.1111/imcb.12291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
6 Li T, Zhu J. Entanglement of CCR5 and Alzheimer's Disease. Front Aging Neurosci 2019;11:209. [PMID: 31447666 DOI: 10.3389/fnagi.2019.00209] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
7 Ellwanger JH, Kaminski VDL, Chies JAB. CCR5 gene editing – Revisiting pros and cons of CCR5 absence. Infection, Genetics and Evolution 2019;68:218-20. [DOI: 10.1016/j.meegid.2018.12.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
8 Jorda A, Cauli O, Santonja JM, Aldasoro M, Aldasoro C, Obrador E, Vila JM, Mauricio MD, Iradi A, Guerra-Ojeda S, Marchio P, Valles SL. Changes in Chemokines and Chemokine Receptors Expression in a Mouse Model of Alzheimer's Disease. Int J Biol Sci 2019;15:453-63. [PMID: 30745834 DOI: 10.7150/ijbs.26703] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
9 Chen Y, Xu L, Xie HQH, Xu T, Fu H, Zhang S, Sha R, Xia Y, Zhao B. Identification of differentially expressed genes response to TCDD in rat brain after long-term low-dose exposure. J Environ Sci (China) 2017;62:92-9. [PMID: 29289296 DOI: 10.1016/j.jes.2017.07.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
10 Choi JY, Hwang CJ, Lee DY, Gu SM, Lee HP, Choi DY, Oh KW, Han SB, Hong JT. (E)-2-Methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) Phenol Ameliorates LPS-Mediated Memory Impairment by Inhibition of STAT3 Pathway. Neuromolecular Med 2017;19:555-70. [PMID: 29052076 DOI: 10.1007/s12017-017-8469-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
11 Lee DY, Hwang CJ, Choi JY, Park MH, Song MJ, Oh KW, Han SB, Park WK, Cho HY, Cho SY, Park HB, Song MJ, Hong JT. KRICT-9 inhibits neuroinflammation, amyloidogenesis and memory loss in Alzheimer's disease models. Oncotarget 2017;8:68654-67. [PMID: 28978145 DOI: 10.18632/oncotarget.19818] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wei C, Luo T, Zou S, Zhou X, Shen W, Ji X, Li Q, Wu A. Differentially expressed lncRNAs and miRNAs with associated ceRNA networks in aged mice with postoperative cognitive dysfunction. Oncotarget 2017;8:55901-14. [PMID: 28915561 DOI: 10.18632/oncotarget.18362] [Cited by in Crossref: 21] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
13 Park JH, Lee DH, Park MS, Jung YS, Hong JT. C‐C chemokine receptor type 5 deficiency exacerbates alcoholic fatty liver disease through pro‐inflammatory cytokines and chemokines‐induced hepatic inflammation. Journal of Gastroenterology and Hepatology 2017;32:1258-64. [DOI: 10.1111/jgh.13657] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
14 Qidwai T. Chemokine genetic polymorphism in human health and disease. Immunol Lett 2016;176:128-38. [PMID: 27262929 DOI: 10.1016/j.imlet.2016.05.018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]